Admittance Technologies
Austin
About Admittance Technologies
Admittance Technologies is committed to improving the quality of life of patients with heart disease through innovative electrical engineering solutions. Admittance will accomplish this goal through the application of CardioVol™, which can interrogate the heart with electric fields, and in real-time distinguish the blood and heart muscle components of these fields. They focus on the blood signal to warn patients of impending heart failure, maximize their hearts’ ejection of blood by properly tuning the pacing of these weakened hearts, and using stroke volume to determine if VT and rapid afib are hemodynamically unstable requiring defibrillation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $5.9M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2015)
- Website: admittancetechnologies.com
- Phone: 5123501187
Industries & Categories
Health Care, Health Diagnostics, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/admittance-technologies-2973529 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.